Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like Addex, Indivior Forge $335M Addiction Disorder Tie-Up January 2, 2018 9 Questionable Drugs Biotechs Are Submitting to the FDA in a Hail Mary Pass March 8, 2017 Massachusetts' Inotek Exploring Strategic Alternatives After Another Glaucoma Trial Failure July 9, 2017
Massachusetts' Inotek Exploring Strategic Alternatives After Another Glaucoma Trial Failure July 9, 2017
